Neptune Technologies & Bioressources Inc  

(Public, TSE:NTB)   Watch this stock  
Find more results for NTB
1.40
-0.02 (-1.41%)
Jul 22 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.38 - 1.42
52 week 1.08 - 1.97
Open 1.42
Vol / Avg. 43,266.00/24,738.00
Mkt cap 114.23M
P/E     -
Div/yield     -
EPS -0.07
Shares 77.95M
Beta 0.66
Inst. own     -
Oct 12, 2016
Q2 2017 Neptune Technologies & Bioressources Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 13, 2016
Neptune Technologies & Bioressources Inc Annual Shareholders Meeting (Estimated)
Jul 12, 2016
Neptune Technologies & Bioressources Inc Extraordinary Shareholders Meeting
Jul 12, 2016
Neptune Technologies & Bioressources Inc Annual Shareholders Meeting
Jul 12, 2016
Q1 2017 Neptune Technologies & Bioressources Inc Earnings Call - Webcast
Jul 11, 2016
Q1 2017 Neptune Technologies & Bioressources Inc Earnings Release
May 26, 2016
Q4 2016 Neptune Technologies & Bioressources Inc Earnings Call
May 25, 2016
Q4 2016 Neptune Technologies & Bioressources Inc Earnings Release
  

Key stats and ratios

Q2 (May '16) 2016
Net profit margin -33.97% -47.85%
Operating margin -21.73% -65.37%
EBITD margin - -53.42%
Return on average assets -14.84% -10.56%
Return on average equity -16.41% -13.74%
Employees 139 -
CDP Score - -

Address

545 Prom du Centropolis Suite 100
LAVAL, QC H7T 0A3
Canada
+1-450-6872262 (Phone)
+1-450-6872272 (Fax)

Website links

Description

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products include Krill-Based Nutraceutical Products, including Neptune Krill Oil (NKO), OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti. The Company's NKO is a marine oil extracted from krill (Euphasia superba). NKO consists of phospholipids, which contain omega-3 fatty acids, including eicosapentaenoic acid and docosahexaenoic acid (EPA & DHA), and antioxidants, such as astaxanthin, vitamin A and vitamin E. The Company sells OCEANO3 directly to consumers in Canada through its online platform (www.oceano3.com), under its brand name.

Officers and directors

Pierre Fitzgibbon Chairman of the Board
Age: 60
James Stuart Hamilton President, Chief Executive Officer, Director
Mario Paradis Chief Financial Officer
Michel Timperio Senior Vice President of Sales - Global Sales
Pierre Lemieux Ph.D. Chief Operating Officer of Acasti
Jean-Daniel Belanger Corporate Secretary and Director - Corporate Affairs
Harlan W. Waksal M.D. Director
Age: 61
Valier Boivin Independent Director
Ronald Denis Independent Director
Adrian Taylor Montgomery Independent Director